Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody (Q33893777)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody |
scientific article |
Statements
1 reference
Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody (English)
1 reference
Hagop Kantarjian
1 reference
Jorge Cortes
1 reference
Tapan Kadia
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Elias Jabbour
1 reference
Sherry Pierce
1 reference
Guillermo Garcia-Manero
1 reference
Koji Sasaki
1 reference
Xuelin Huang
1 reference
Michael Rytting
1 reference
Deborah Thomas
1 reference
16 January 2015
1 reference
1 reference
90
1 reference
193-196
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference